Neuromodulation: Spinal Cord Stimulation Devices Market
Neuromodulation: Spinal Cord Stimulation Devices Market
$4,750.00
According to a recent CDC study, 20.1% of adults had chronic pain and 7.4% of adults had chronic pain that frequently limited life or work activities with similar numbers being reported in Europe. In 2021, the spinal cord stimulation (SCS) devices market was worth nearly $2.9 bn. Market drivers of the SCS devices market through 2026 will be driven by an aging population and an increase in selected conditions (eg back/leg pain, and a growing number of indications) that result in debilitating and unrelenting chronic pain.
Publisher: Meddevicetracker
- Highlights
- Description
- Contents
Executive Summary
This comprehensive medical market and technology report provides an overview and in-depth market analysis of spinal cord stimulators used to treat chronic pain. The forecast period of this report is from 2021 to 2026. The spinal cord stimulation (SCS) devices market was worth $2,890.5m in 2021, and is estimated to increase in size to be worth $3,429.0m by 2026. Growth is expected to be moderate as the SCS devices market, along with many other medical device markets, is currently recovering from a major economic downturn due to the COVID-19 pandemic
Overview
According to a recent CDC study, 20.1% of adults had chronic pain and 7.4% of adults had chronic pain that frequently limited life or work activities with similar numbers being reported in Europe. In 2021, the spinal cord stimulation (SCS) devices market was worth nearly $2.9 bn. Market drivers of the SCS devices market through 2026 will be driven by an aging population and an increase in selected conditions (eg back/leg pain, and a growing number of indications) that result in debilitating and unrelenting chronic pain. Another potential area of market growth may be the Parkinson’s disease community. Should SCS technology be indicated for treating symptoms of the disease without the need of pharmaceutical intervention, the resulting growth will be substantial. Market limiters include a lack of surgeons trained in SCS implantation, adequate facilities, and the components needed to manufacture SCS devices. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global markets for spinal cord stimulation devices for the treatment of chronic pain. Countries covered by this report include the US, five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and the Rest of World (RoW). The forecast range for this report is 2021–26.
The report provides the following useful information:
- an overview of chronic pain disorders
- key statistics on selected forms of chronic pain
- medical device product portfolios offered by manufacturers
- insight into developing and potentially disruptive technologies
- in-depth market and competitive analysis.
Table of Contents
Executive Summary ………………………………………………………………………. ES-1
i. Chronic pain overview…………………………………………………………………………………………..ES-1
ii. Global spinal cord stimulation products market………………………………………………………ES-1
a. Market drivers and limiters……………………………………………………………………….ES-3
b. Technology trends …………………………………………………………………………………..ES-4
c. Market leaders………………………………………………………………………………………..ES-5
d. Competitive strategies……………………………………………………………………………..ES-6
e. Emerging competition………………………………………………………………………………ES-6
iii. Methodology……………………………………………………………………………………………………..ES-8
Exhibit ES-1: Global spinal cord stimulation products market forecast ($m), 2021–26…….ES-2
Exhibit ES-2: Global spinal cord stimulation products market, by country/region, 2021 ….ES-3
Exhibit ES-3: Drivers and limiters of market growth – spinal cord stimulators………………..ES-4
1. Clinical Overview …………………………………………………………………………1-1
1.1 The nervous system …………………………………………………………………………………………… 1-1
1.2 The mechanics of pain ……………………………………………………………………………………….. 1-1
1.3 Pain statistics ……………………………………………………………………………………………………. 1-3
1.4 Cost of pain ………………………………………………………………………………………………………. 1-4
1.5 Pain management……………………………………………………………………………………………… 1-5
1.6 Procedural therapies for treating pain …………………………………………………………………. 1-5
1.7 Spinal cord stimulation ………………………………………………………………………………………. 1-5
1.8 Bibliography ……………………………………………………………………………………………………. 1-10
Exhibit 1-1: Selected types of chronic pain, estimated US prevalence……………………………. 1-4
Exhibit 1-2: Simplified diagram of implantation of a spinal cord stimulation device………… 1-7
2. Neuromodulation Technologies for the Treatment of Pain………………….2-1
2.1 Spinal cord stimulation systems ………………………………………………………………………….. 2-1
2.2 Spinal cord stimulation products…………………………………………………………………………. 2-4
2.3 Developments in spinal cord stimulation technology …………………………………………….. 2-8
2.4 Bibliography ……………………………………………………………………………………………………. 2-13
Exhibit 2-1: Selected leading spinal cord stimulation system(s)…………………………………….. 2-6
Exhibit 2-2: Stimulation device startups and nerve targets…………………………………………. 2-10
3. Spinal Cord Stimulation Products Market…………………………………………3-1
3.1 Global market insights……………………………………………………………………………………….. 3-1
3.1.1 Market value………………………………………………………………………………………. 3-1
3.1.2 Technology trends ………………………………………………………………………………. 3-4
3.1.3 Market drivers and limiters ………………………………………………………………….. 3-5
3.1.4 Market leaders……………………………………………………………………………………. 3-7
3.1.5 Competitive strategies…………………………………………………………………………. 3-7
3.1.6 Emerging competition …………………………………………………………………………. 3-7
3.2 Global competitors ……………………………………………………………………………………………. 3-8
3.3 Market forecast……………………………………………………………………………………………….. 3-13
3.3.1 Market forecast: US …………………………………………………………………………… 3-13
3.3.2 Market forecast: five major European markets……………………………………… 3-15
3.3.3 Market forecast: Japan ………………………………………………………………………. 3-17
3.3.4 Market forecast: rest of world…………………………………………………………….. 3-19
3.4 Bibliography ……………………………………………………………………………………………………. 3-22
Exhibit 3-1: Global spinal cord stimulation products market forecast ($m), 2021–26………. 3-2
Exhibit 3-2: Global spinal cord stimulation products market, share by country/region, 2021 ……………………………………………………………………… 3-3
Exhibit 3-3: Global spinal cord stimulation product sales, global market forecast ($m), by country/region, 2021–26……………………………………………………………………………… 3-4
Exhibit 3-4: Drivers and limiters of market growth – spinal cord stimulators………………….. 3-6
Exhibit 3-5: Global spinal cord stimulation products market, share by supplier, 2021……… 3-9
Exhibit 3-6: Medtronic, revenues by segment, FY2021………………………………………………. 3-10
Exhibit 3-7: Abbott, revenues by segment, FY2020……………………………………………………. 3-11
Exhibit 3-8: Boston Scientific, revenues by segment, FY2020 ……………………………………… 3-12
Exhibit 3-9: Nevro, revenues by segment, FY2020 …………………………………………………….. 3-13
Exhibit 3-10: US spinal cord stimulation device implantations, procedure volumes forecast, 2021–26…………………………………………………………. 3-14
Exhibit 3-11: US spinal cord stimulation product sales, market forecast ($m), 2021–26 … 3-15
Exhibit 3-12: 5 Euro spinal cord stimulation device implantations, procedure volumes forecast, 2021–26 …………………………………………………………………………………………………… 3-16
Exhibit 3-13: 5 Euro spinal cord stimulation product sales, market forecast ($m), 2021–26 …………………………………………………………………… 3-17
Exhibit 3-14: Japanese spinal cord stimulation device implantations, procedure volumes forecast, 2021–26 ……………………………………………………………………………………… 3-18
Exhibit 3-15: Japanese spinal cord stimulation product sales, market forecast ($m), 2021–26 …………………………………………………………………… 3-19
Exhibit 3-16: RoW spinal cord stimulation product sales, market forecast ($m), 2021–26 …………………………………………………………………… 3-21
© Informa UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Disease Analysis: Non-Alcoholic Steatohepatitis (NASH) 
Sign up to the